Penn Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-248,844	Closed	-$4.62M	–	144
2024 Q1	$4.62M	Buy	248,844 +1,520	+0.6%	+$28.2K	0.41%	79
2023 Q4	$7.77M	Sell	247,324 -41,959	-15%	-$1.32M	0.71%	66
2023 Q3	$6.05M	Buy	289,283 +102,280	+55%	+$2.14M	0.62%	73
2023 Q2	$4.48M	Buy	+187,003	New	+$4.48M	0.44%	75